News

Under the terms of the agreement, iCAD will pay $2 million in cash and $3 million in shares of iCAD common stock. The number of shares issued will

LOR-2040 is currently in an advanced Phase II clinical study in patients with relapsed or refractory acute myeloid leukemia. To provide an adequate supply of LOR-2040 for ongoing

The trial is being conducted in the US, India and Poland. Data collection will be finalized following completion of treatment of the last patients, expected near the end

Taro had received tentative approval for this abbreviated new drug application in October 2007. The company plans to market the product through its US affiliate, Taro Pharmaceuticals USA.

The ATS AP360 heart valve maximizes hemodynamic performance with a new supra-annular cuff design that facilitates implantation, the company said. In a response to the highly individualized and

Medco said that it will provide mail, retail and specialty pharmacy services for all of Coventry’s Medicare programs, covering approximately one million members with annual drug spend exceeding

Prior to joining Danube, since 2004, Dr Levy served as corporate vice president and chief medical officer of Bausch & Lomb worldwide. Dr Levy joined Bausch & Lomb

This is the second Phase II trial currently underway to evaluate MN-221 in various populations of asthma patients. This randomized, open-label, placebo-controlled Phase II clinical trial will involve

This clinical study, which will be recruiting volunteers for four treatment groups, is being conducted at a Phase I trial site in Honolulu. Results should be known within